{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:24:02Z","timestamp":1791339842476,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Project of Basic Research Fund of Henan Institute of Medical and Pharmaceutical Sciences"},{"name":"the Medical Science and Technology Research Project of Henan Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Irisin is a peptide hormone with notable anti-inflammatory and metabolic regulatory effects but has limited clinical utility due to its extremely short plasma half-life (&lt; 1\u2009h). In this study, we engineered an albumin-binding domain (ABD)-conjugated Irisin (ABD-Irisin) fusion protein to significantly extend half-life and enhance therapeutic potency. ABD-Irisin fusion protein was successfully expressed in HEK-293F cells, purified, and validated through functional assays including lipid droplet reduction and western blot assays. Pharmacokinetic studies demonstrated that ABD-Irisin markedly prolonged the plasma half-life of Irisin to approximately 10\u2009h, substantially surpassing native Irisin, and showed enhanced tissue distribution in vivo. In a lipopolysaccharide (LPS) induced mouse model of systemic inflammation, both Irisin and ABD-Irisin significantly reduced plasma TNF-\u03b1 levels, splenomegaly, and histopathological inflammation. Notably, ABD-Irisin (500\u2009\u03bcg\/kg) demonstrated significantly enhanced suppression of plasma IL-6 and splenic inflammatory cytokines (IL-1\u03b2, IL-10) compared to native Irisin. Single-cell RNA sequencing further revealed that ABD-Irisin robustly suppressed the activation of the TLR4-MyD88-NF-\u03baB signaling axis in bone marrow immune cells, outperforming unmodified Irisin. These findings demonstrate that ABD conjugation is an effective strategy to enhance the pharmacokinetics and anti-inflammatory efficacy of Irisin, highlighting ABD-Irisin as a promising therapeutic candidate for inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s42003-025-09000-z","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:55:49Z","timestamp":1763416549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Engineered long-acting Irisin-albumin binding domain fusion protein for enhanced anti-inflammatory efficacy in lipopolysaccharide-induced systemic inflammation"],"prefix":"10.1038","volume":"8","author":[{"given":"Jicun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3666-7063","authenticated-orcid":false,"given":"Lie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2500-7531","authenticated-orcid":false,"given":"Chenxi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-3895","authenticated-orcid":false,"given":"Jianxiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"9000_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, P. et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463\u2013468 (2012).","journal-title":"Nature"},{"key":"9000_CR2","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s11011-024-01412-w","volume":"39","author":"RAL De Sousa","year":"2024","unstructured":"De Sousa, R. A. L. Exercise-produced Irisin effects on brain-related pathological conditions. Metab. Brain Dis. 39, 1679\u20131687 (2024).","journal-title":"Metab. Brain Dis."},{"key":"9000_CR3","doi-asserted-by":"publisher","first-page":"101680","DOI":"10.1016\/j.arr.2022.101680","volume":"80","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Wu, X., Liang, J., Kirberger, M. & Chen, N. Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res. Rev. 80, 101680 (2022).","journal-title":"Ageing Res. Rev."},{"key":"9000_CR4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.cell.2018.10.025","volume":"175","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Irisin mediates effects on bone and fat via \u03b1V integrin receptors. Cell 175, 1756\u20131768 (2018).","journal-title":"Cell"},{"key":"9000_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2023.09.001","volume":"62","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Irisin as an agent for protecting against osteoporosis: a review of the current mechanisms and pathways. J. Adv. Res. 62, 175\u2013186 (2024).","journal-title":"J. Adv. Res."},{"key":"9000_CR6","doi-asserted-by":"publisher","first-page":"962968","DOI":"10.3389\/fendo.2022.962968","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu, S., et al. Role of irisin in physiology and pathology. Front. Endocrinol. 13, 962968 (2022).","journal-title":"Front. Endocrinol."},{"key":"9000_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/molecules27031118","volume":"27","author":"R Waseem","year":"2022","unstructured":"Waseem, R. et al. FNDC5\/Irisin: Physiology and pathophysiology. Molecules 27, 1118 (2022).","journal-title":"Molecules"},{"key":"9000_CR8","doi-asserted-by":"publisher","first-page":"111676","DOI":"10.1016\/j.mce.2022.111676","volume":"552","author":"JJ Slate-Romano","year":"2022","unstructured":"Slate-Romano, J. J., Yano, N. & Zhao, T. C. Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome. Mol. Cell. Endocrinol. 552, 111676 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"9000_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1210\/endrev\/bnab003","volume":"42","author":"S Maak","year":"2021","unstructured":"Maak, S., Norheim, F., Drevon, C. A. & Erickson, H. P. Progress and challenges in the biology of FNDC5 and Irisin. Endocr. Rev. 42, 436\u2013456 (2021).","journal-title":"Endocr. Rev."},{"key":"9000_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1517\/17425247.2015.993313","volume":"12","author":"D Sleep","year":"2015","unstructured":"Sleep, D. Albumin and its application in drug delivery. Expert Opin. Drug Deliv. 12, 793\u2013812 (2015).","journal-title":"Expert Opin. Drug Deliv."},{"key":"9000_CR11","doi-asserted-by":"publisher","first-page":"1346328","DOI":"10.3389\/fimmu.2024.1346328","volume":"15","author":"MM Harmsen","year":"2024","unstructured":"Harmsen, M. M., Ackerschott, B. & de Smit, H. Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species. Front. Immunol. 15, 1346328 (2024).","journal-title":"Front. Immunol."},{"key":"9000_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1089\/hgtb.2017.057","volume":"28","author":"G Garaulet","year":"2017","unstructured":"Garaulet, G. et al. Display of the albumin-binding domain in the envelope improves lentiviral vector bioavailability. Gene Ther. Methods 28, 340\u2013351 (2017).","journal-title":"Gene Ther. Methods"},{"key":"9000_CR13","doi-asserted-by":"publisher","first-page":"123237","DOI":"10.1016\/j.lfs.2024.123237","volume":"359","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Albumin binding domain fusion improved the therapeutic efficacy of inhibitor of differentiation-2 protein in colitis mice. Life Sci. 359, 123237 (2024).","journal-title":"Life Sci."},{"key":"9000_CR14","doi-asserted-by":"publisher","first-page":"173650","DOI":"10.1016\/j.ejphar.2020.173650","volume":"890","author":"H Tan","year":"2021","unstructured":"Tan, H. et al. Albumin-binding domain extends half-life of glucagon-like peptide-1. Eur. J. Pharmacol. 890, 173650 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"9000_CR15","doi-asserted-by":"publisher","first-page":"174152","DOI":"10.1016\/j.ejphar.2021.174152","volume":"904","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Design and biological evaluation of novel long-acting adalimumab Fab conjugated with the albumin binding domain. Eur. J. Pharmacol. 904, 174152 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"9000_CR16","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1002\/mco2.557","volume":"5","author":"Q Li","year":"2024","unstructured":"Li, Q., et al. Half-life extension of single-domain antibody\u2013drug conjugates by albumin binding moiety enhances antitumor efficacy. MedComm. 5, e557 (2024).","journal-title":"MedComm"},{"key":"9000_CR17","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.1074\/jbc.RA120.014168","volume":"295","author":"CK Wang","year":"2020","unstructured":"Wang, C. K., Amiss, A. S., Weidmann, J. & Craik, D. J. Structure-activity analysis of truncated albumin-binding domains suggests new lead constructs for potential therapeutic delivery. J. Biol. Chem. 295, 12143\u201312152 (2020).","journal-title":"J. Biol. Chem."},{"key":"9000_CR18","doi-asserted-by":"publisher","first-page":"1893888","DOI":"10.1080\/19420862.2021.1893888","volume":"13","author":"S Mester","year":"2021","unstructured":"Mester, S., et al. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRnin vitroandin vivo. MAbs. 13, 1893888 (2021).","journal-title":"MAbs"},{"key":"9000_CR19","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11030-024-10933-6","volume":"29","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Gold nanoparticles-conjugation of irisin enhances therapeutic effect by improving cardiac function and attenuating inflammation in sepsis. Mol. Divers. 29, 1557\u20131568 (2025).","journal-title":"Mol. Divers."},{"key":"9000_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8521756","volume":"2021","author":"H Li","year":"2021","unstructured":"Li, H. et al. The effect of Irisin as a metabolic regulator and its therapeutic potential for obesity. Int. J. Endocrinol. 2021, 1\u201312 (2021).","journal-title":"Int. J. Endocrinol."},{"key":"9000_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/ijms25010275","volume":"25","author":"LPP Pontes","year":"2023","unstructured":"Pontes, L. P. P. et al. Resistance and aerobic training were effective in activating different markers of the browning process in obesity. Int. J. Mol. Sci. 25, 275 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"9000_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.it.2017.01.004","volume":"38","author":"S Boettcher","year":"2017","unstructured":"Boettcher, S. & Manz, M. G. Regulation of inflammation- and infection-driven hematopoiesis. Trends Immunol. 38, 345\u2013357 (2017).","journal-title":"Trends Immunol."},{"key":"9000_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11239-019-01862-5","volume":"48","author":"N Kovuru","year":"2019","unstructured":"Kovuru, N., Raghuwanshi, S. & Gutti, R. K. Exosome mediated differentiation of megakaryocytes: a study on TLR mediated effects. J. Thromb. Thrombolysis 48, 171\u2013173 (2019).","journal-title":"J. Thromb. Thrombolysis"},{"key":"9000_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras, E. M. et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol. 18, 607\u2013618 (2016).","journal-title":"Nat. Cell Biol."},{"key":"9000_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147\u2013161 (2018).","journal-title":"Cell"},{"key":"9000_CR26","doi-asserted-by":"publisher","first-page":"130857","DOI":"10.1016\/j.ijbiomac.2024.130857","volume":"265","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Irisin delays the onset of type 1 diabetes in NOD mice by enhancing intestinal barrier. Int. J. Biol. Macromol. 265, 130857 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"9000_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/biology13100809","volume":"13","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Exercise promotes hippocampal neurogenesis in T2DM mice via Irisin\/TLR4\/MyD88\/NF-\u03baB-mediated neuroinflammation pathway. Biology 13, 809 (2024).","journal-title":"Biology"},{"key":"9000_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jare.2024.04.013","volume":"69","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Irisin alleviates obesity-induced bone loss by inhibiting interleukin 6 expression via TLR4\/MyD88\/NF-\u03baB axis in adipocytes. J. Adv. Res. 69, 343\u2013359 (2025).","journal-title":"J. Adv. Res."},{"key":"9000_CR29","doi-asserted-by":"publisher","first-page":"6153235","DOI":"10.1155\/sci\/6153235","volume":"2024","author":"H Jia","year":"2024","unstructured":"Jia, H., Moore, M., Wadhwa, M., Burns, C. & Sopper, S. Human iPSC\u2013derived endothelial cells exhibit reduced immunogenicity in comparison with human primary endothelial cells. Stem Cells Int. 2024, 6153235 (2024).","journal-title":"Stem Cells Int."},{"key":"9000_CR30","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.2147\/JIR.S335671","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Albumin\/globulin ratio as yin\u2013yang in rheumatoid arthritis and its correlation to inflamm-aging cytokines. J. Inflamm. Res. 14, 5501\u20135511 (2021).","journal-title":"J. Inflamm. Res."},{"key":"9000_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/membranes11090715","volume":"11","author":"A Chyt\u0142a","year":"2021","unstructured":"Chyt\u0142a, A., Gajdzik-Nowak, W., Biernatowska, A., Sikorski, A. F. & Czogalla, A. High-level expression of palmitoylated MPP1 recombinant protein in mammalian cells. Membranes 11, 715 (2021).","journal-title":"Membranes"},{"key":"9000_CR32","doi-asserted-by":"publisher","first-page":"1373077","DOI":"10.3389\/fmicb.2024.1373077","volume":"15","author":"M Yang","year":"2024","unstructured":"Yang, M. et al. Irisin alleviated the reproductive endocrinal disorders of PCOS mice accompanied by changes in gut microbiota and metabolomic characteristics. Front. Microbiol. 15, 1373077 (2024).","journal-title":"Front. Microbiol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09000-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09000-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09000-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:55:50Z","timestamp":1763416550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09000-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9000"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09000-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1592"}}